Jump to content

Main menu Navigation ●Main page ●Contents ●Current events ●Random article ●About Wikipedia ●Contact us ●Donate Contribute ●Help ●Learn to edit ●Community portal ●Recent changes ●Upload file

●Create account ●Log in ●Create account ● Log in Pages for logged out editors learn more ●Contributions ●Talk

(Top) 1 See also 2 References

WB-4101

●中文 Edit links ●Article ●Talk ●Read ●Edit ●View history Tools Actions ●Read ●Edit ●View history General ●What links here ●Related changes ●Upload file ●Special pages ●Permanent link ●Page information ●Cite this page ●Get shortened URL ●Download QR code ●Wikidata item Print/export ●Download as PDF ●Printable version Appearance From Wikipedia, the free encyclopedia

WB-4101
Identifiers

IUPAC name 2-(2,6-Dimethoxyphenoxyethyl)aminomethyl-1,4-benzodioxane
CAS Number	613-67-2^Y
PubChem CID	5685
IUPHAR/BPS	499
ChemSpider	5483
UNII	E9H51OIT2B
CompTox Dashboard (EPA)	DTXSID1043885
Chemical and physical data
Formula	C₁₉H₂₃NO₅
Molar mass	345.395 g·mol⁻¹
3D model (JSmol)	Interactive image
SMILES COc1cccc(c1OCCNCC2COc3ccccc3O2)OC
InChI InChI=1S/C19H23NO5/c1-21-17-8-5-9-18(22-2)19(17)23-11-10-20-12-14-13-24-15-6-3-4-7-16(15)25-14/h3-9,14,20H,10-13H2,1-2H3 Key:GYSZUJHYXCZAKI-UHFFFAOYSA-N

WB-4101 is a compound which acts as an antagonist at the α_1B-adrenergic receptor. It was one of the first selective antagonists developed for this receptor and was invented in 1969, but is still commonly used in research into adrenergic receptors, especially as a lead compound from which to develop more selective drugs.^[1]^[2]^[3]^[4]^[5]^[6]

References[edit]

^ Green PN, Shapero M, Wilson C (March 1969). "The synthesis and pharmacological properties of a series of 2-substituted aminomethyl-1,4-benzodioxanes". Journal of Medicinal Chemistry. 12 (2): 326–9. doi:10.1021/jm00302a033. PMID 5791620.

^ Morrow AL, Creese I (April 1986). "Characterization of alpha 1-adrenergic receptor subtypes in rat brain: a reevaluation of [3H]WB4104 and [3H]prazosin binding". Molecular Pharmacology. 29 (4): 321–30. PMID 3010073.

^ Melchiorre C, Bolognesi ML, Budriesi R, Chiarini A, Giardinà D, Minarini A, et al. (April 1998). "Search for selective antagonists at alpha 1-adrenoreceptors: neutral or negative antagonism?". Farmaco. 53 (4): 278–86. doi:10.1016/S0014-827X(98)00022-6. PMID 9658586.

^ Melchiorre C, Angeli P, Bolognesi ML, Chiarini A, Giardinà D, Gulini U, et al. (March 2000). "Alpha 1-adrenoreceptor antagonists bearing a quinazoline or a benzodioxane moiety". Pharmaceutica Acta Helvetiae. 74 (2–3): 181–90. doi:10.1016/S0031-6865(99)00049-7. PMID 10812956.

^ Fumagalli L, Pallavicini M, Budriesi R, Gobbi M, Straniero V, Zagami M, et al. (December 2012). "Affinity and activity profiling of unichiral 8-substituted 1,4-benzodioxane analogues of WB4101 reveals a potent and selective α1B-adrenoceptor antagonist". European Journal of Medicinal Chemistry. 58: 184–91. doi:10.1016/j.ejmech.2012.09.049. PMID 23124215.

^ Fumagalli L, Pallavicini M, Budriesi R, Bolchi C, Canovi M, Chiarini A, et al. (August 2013). "6-methoxy-7-benzofuranoxy and 6-methoxy-7-indolyloxy analogues of 2-[2-(2,6-Dimethoxyphenoxy)ethyl]aminomethyl-1,4-benzodioxane (WB4101):1 discovery of a potent and selective α1D-adrenoceptor antagonist". Journal of Medicinal Chemistry. 56 (16): 6402–12. doi:10.1021/jm400867d. PMID 23902232.